SYNEOS HEALTH, INC.
Presenter SpeechSteven Couche (Analysts)Hi. Welcome back to the 2022 Jefferies Healthcare Conf...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Syneos Health, Inc. is a biopharmaceutical solutions company that utilizes outsourced clinical drug development and commercialization services. The Company operates through two business segments: Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers global services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development. The Clinical Solutions segment offers individual services including product development, project management, protocol development, investigational site recruitment, and clinical monitoring. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions (public relations, advertising, and medical communications), and consulting services. The Company's customers include small, mid-sized, and large companies in the biopharmaceutical, biotechnology, and medical device industries.
| 1st Jan change | Capi. | |
|---|---|---|
| +3.13% | 43.43B | |
| +48.49% | 41.69B | |
| +8.49% | 41.31B | |
| -10.82% | 27.14B | |
| +8.26% | 25.28B | |
| -23.69% | 18.47B | |
| +32.83% | 12.59B | |
| +1.58% | 12.33B | |
| +6.63% | 11.03B |
